A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2004
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6821988 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
11/23/2004	US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004	US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004	US6821978 Xanthine phosphodiesterase V inhibitors
11/23/2004	US6821973 Compounds
11/23/2004	US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia
11/23/2004	US6821966 Antiinflammatory agents
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation
11/23/2004	US6821950 Antagonist of a g protein-coupled receptor, which has no agonist activity, and which has a cyclic or constrained acyclic structure
11/23/2004	US6821394 Process of extracting from haw-pit by dry distillation and its device
11/23/2004	CA2329788C Quinoline derivatives
11/23/2004	CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004	CA2161346C Sulfonamides and derivatives thereof that modulate the activity of endothelin
11/23/2004	CA2125288C Serotoninergic ergoline derivatives
11/23/2004	CA2075077C Stevia extract-containing liquid internal medicine and method of preparing the same
11/18/2004	WO2004099182A1 Zinc salt of (s)-omeprazole
11/18/2004	WO2004099181A1 Barium salt of benzimidazole derivative
11/18/2004	WO2004098670A1 Method of regenerating tooth germ
11/18/2004	WO2004098610A1 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
11/18/2004	WO2004098609A1 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
11/18/2004	WO2004098599A2 Proton pump inhibitors for the treatment of lower abdominal disorders
11/18/2004	WO2004082573A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
11/18/2004	WO2004073613A3 A medicine and food
11/18/2004	WO2004071381A3 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
11/18/2004	WO2004038406A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004	US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
11/18/2004	US20040229897 Aid in cytokine biosynthesis
11/18/2004	US20040229887 Novel imidazopyrimidinyl and imidazopyri dinyl derivatives
11/18/2004	US20040229885 Xanthine phosphodiesterase V inhibitors
11/18/2004	US20040229884 Sodium channel blockers
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229879 CRF receptor antagonists and methods relating thereto
11/18/2004	US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004	US20040229859 Beta-amino acid compounds as integrin antagonists
11/18/2004	US20040229851 2-Propylidene-19-nor-vitamin D compounds
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229790 Substance having an activity which modulates or inhibits proliferation of AILIM(activation inducible lymphocyte immunomodulatory molecule)-expressing cells or production of a cytokine; for treatment of rheumatoid arthritis, osteoarthritis
11/18/2004	US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004	US20040228868 induces apoptosis in mammalian cancer cells; irinotecan; kits
11/18/2004	CA2524268A1 Proton pump inhibitors for the treatment of lower abdominal disorders
11/17/2004	EP1477482A1 Novel phenylalanine derivative
11/17/2004	EP1477183A1 Botulinum toxins for modulating cholinergic controlled secretions
11/17/2004	EP1477181A1 Method of stimulating growth and resistance to diseases of aquatic organisms
11/17/2004	EP1477180A1 Inhibitors of proteasomal activity for stimulating bone and hair growth
11/17/2004	EP1477178A2 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
11/17/2004	EP1477171A1 Intestinal mineral absorption capacity improver
11/17/2004	EP1476752A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
11/17/2004	EP1476574A2 RNA INTERFERENCE MEDIATED INHIBITION OF TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/17/2004	EP1476545A2 Aggrecanase molecules
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476466A1 Management of mucosal viscosity by tff monomer peptides
11/17/2004	EP1476465A1 Method for producing interferon
11/17/2004	EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina)
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/17/2004	EP1476454A1 Binding epitopes for helicobacter pylori and use thereof
11/17/2004	EP1476445A1 Tricyclic n-acyl compounds
11/17/2004	EP1476442A2 Lansoprazole polymorphs and processes for preparation thereof
11/17/2004	EP1476438A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/17/2004	EP1476435A1 Novel pyridin- and pyrimidin-derivatives
11/17/2004	EP1476434A2 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
11/17/2004	EP1476432A1 Therapeutic substituted indazole derivatives
11/17/2004	EP1476431A1 Tricyclic pyrazole derivatives for the treatment of inflammation
11/17/2004	EP1476429A1 Novel pyridine- and quinoline-derivatives
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1476167A1 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
11/17/2004	EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004	EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476153A2 Method of treating and preventing bone loss
11/17/2004	EP1476145A1 Anti-nausea and anti-vomiting activity of cannabidiol compounds
11/17/2004	EP1476143A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
11/17/2004	EP1476136A1 Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation
11/17/2004	EP1401442B1 S-omeprazole (esomeprazole) inclusion complex with cyclodextrins
11/17/2004	EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/17/2004	EP1318804B1 Iron compositions
11/17/2004	EP1242436B1 Oligosaccharide mixture
11/17/2004	EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
11/17/2004	EP1214323B1 Indoloazepines as vasopressin receptor antagonists
11/17/2004	EP1171120A4 Methods for alleviating discomfort of a hot flash and compositions therefor
11/17/2004	EP1159457A4 T cell receptor vbeta beta-jbeta) sequence and methods for its detection
11/17/2004	EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004	EP1137667B1 Analogues of glp-1
11/17/2004	EP1109809B1 Pyrroloquinolines for treatment of obesity
11/17/2004	EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1)
11/17/2004	EP1087762B1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP0979245B1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/17/2004	EP0923569B1 Butyric acid matrix metalloproteinase inhibitors
11/17/2004	EP0907658B1 Neuropeptide y agonists

1 ... 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 ... 1258